Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
Z. Fang, L. Peng, R. Filler, K. Suzuki, A. McNamara, Q. Lin, P. A. Renauer, L. Yang, B. Menasche, A. Sanchez, P. Ren, Q. Xiong, M. Strine, P. Clark, C. Lin, , S. Chen
This study evaluates an Omicron-specific mRNA vaccine, showing it elicits strong antibody responses and outperforms WT boosters against Omicron and Delta variants.
bioRxiv · Feb 14, 2022Immunology